Symbol Lookup

Thursday May 23, 2013 7:37 PM ET. Data delayed 15 minutes.
28.32
0.24 (0.85%)
Bid/Lots
27.50/5
Ask/Lots
29.48/2
Open/Prev Close
27.88/28.08
Day Range
27.78-28.34
52-Week Range
16.93-33.29
Vol/Avg Daily Vol
95.1K/242.4K
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

2 New Today
Medifast, Inc. Announces New Take Shape for Life Executive Vice President
3 hours ago by PR Newswire

Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven portion-controlled weight-loss products and programs, announced today the appointment of Jeannette M. Mills to Executive Vice President, Take Sha...

Medifast, Inc. Announces Appointment of New Independent Director
3 hours ago by PR Newswire

Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven portion-controlled weight-loss products and programs, announced today the appointment of Kevin G. Byrnes to its Board of Directors and the Compan...

Medifast, Inc. to Participate in Citi's Global Consumer Conference
8:00AM ET on Thursday May 16, 2013 by PR Newswire

Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven portion-controlled weight-loss products and programs, announced today that Michael C. MacDonald, Chairman and Chief Executive Officer, Margaret S...

Medifast Edges Lower Late; Q1 EPS Beats Street by $0.09, Sales Ahead - Guides Q2 Below Consensus, FY2013 Straddles
4:19PM ET on Wednesday May 08, 2013 by Midnight Trader
04:19 PM EDT, 05/08/2013 (MidnightTrader) -- Medifast Inc. (MED) is down 0.2% in late trade after the company reported Q1 earnings of $0.43, topping analyst estimates of $0.34 per share, and higher compared to earnings of $0.29 per share reported...
Medifast, Inc. Announces First Quarter 2013 Financial Results
4:05PM ET on Wednesday May 08, 2013 by PR Newswire

Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today reported financial results for the first quarter ended March 31, 2013.

Company Information

Medifast, Inc. (Medifast) is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products. Medifast's product lines include weight and disease management, meal replacement, and vitamins. The Company's operations are primarily conducted through five of its wholly owned subsidiaries: Jason Pharmaceuticals, Inc. (Jason), Take Shape for Life, Inc. (TSFL), Jason Enterprises, Inc., Jason Properties, LLC and Seven Crondall, LLC. The Company expanded the Medifast product line during the year ended December 31, 2011, by introducing several new products. The products introduced included the Medifast Spiced Pancake, an addition to the Pancake line, including Original and Chocolate Chip varieties. It offers a variety of weight and disease management products under the Medifast and Essential brands and for select private label customer. During 2011, the Company opened 31 new Medifast Weight Control Centers.

CONTACT INFORMATION

Headquarters11445 Cronhill Dr.
OWINGS MILLS, MD, United States 21117
Phone410-581-8042
Fax410-581-8070

EXECUTIVE OFFICERS

Chairman of the Board, Chief Executive OfficerMichael MacDonald
President, Chief Operating Officer, DirectorMargaret Sheetz
Chief Financial OfficerTimothy Robinson
Director of Finance – Supply ChainJoseph Kelleman
Executive Vice President, General Counsel, DirectorJason Groves

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • Standard & Poor's Stock Report

    Standard & Poor's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$387.8MBeta1.80
Revenue (TTM)$363.8MEPS$1.29
Shares Out.13.8MBook Value$6.52
Dividend Yield0.00%P/E21.8x
Annual Dividend Rate$0.00Price/Sales (TTM)1.1
Ex-Div Date1/1/01P/Cash Flow (TTM)13.2x
Pay Date1/1/01Operating Margin7.06%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample